INS and liver disorder: Silymarin is found to be able to intervene in multiple therapeutic targets of liver diseases, the fat accumulation process in liver, hepatocyte mitochondria function and even insulin resistance are modulated with silymarin treatment (Federico et al., 2017; Gillessen and Schmidt, 2020).